Home Tetra Bio-Pharma

Tetra Bio-Pharma

In operation
IPO
Cannabinoid-Derived Drug Developer

Basic Information

Tetra Bio-Pharma focuses on developing cannabinoid-derived drugs using the supportive scientific validation and safety data required by the pharmaceutical industry. Tetra Bio-Pharma's initial focus is on the therapeutic areas of inflammation, pain, ophthalmology, and oncology through a robust pipeline utilizing multiple delivery systems.
Tetra Bio Pharma, Inc.
Ottawa,Ontario,Canada
101~500 people
January 01, 2015
TetraInvestors@LifeSciAdvisors.com